The Centers for Disease Control and Prevention (CDC) has reversed its previous guidelines on COVID-19 isolation, stating that a five-day isolation period is no longer necessary for those who have tested positive for the virus. This change in guidance aligns COVID-19 treatment with that of flu and other respiratory illnesses.
According to the CDC, this unified approach to addressing risks from respiratory viral illnesses, including COVID-19, flu, and RSV, will make recommendations easier to follow and more likely to be adopted. The agency also highlighted that adopting a unified approach does not rely on individuals testing for illness, which can be an uneven practice.
In contrast to its previous recommendation in 2021, the CDC now advises individuals to return to normal activities once their symptoms have been improving for at least 24 hours, and if a fever was present, it has subsided without the use of fever-reducing medication. However, the CDC still emphasizes the importance of wearing well-fitting masks and maintaining physical distance from others.
The Wall Street Journal reported that most Americans have already stopped getting tested for COVID-19 and following isolation protocols as the effects of the virus have become routine. The CDC acknowledged a significant decrease in hospitalizations compared to the peak of the pandemic in 2020 and 2021. Hospital admissions have dropped by over 60% compared to 2021, with hospitalizations now at approximately 900,000, down from 2.5 million in 2021. Furthermore, COVID-19-related deaths have also significantly decreased from over 450,000 in 2021 to around 75,000 in 2023.
Despite these positive trends, the CDC still considers COVID-19 a public health threat and remains firm on its “vaccine” mandate. The agency urges individuals to get vaccinated to protect themselves and their communities from the virus.
In another development, researchers from the Global Vaccine Data Network have revealed the severe side effects of COVID-19 vaccines among vaccinated individuals. The study found cases of heart inflammation or myocarditis associated with the Pfizer mRNA shot, particularly in the first, second, and third doses.
Moderna's second shot also showed a higher number of myocarditis cases. Additionally, the AstraZeneca vaccine was linked to pericarditis, an inflammation of the pericardium, and an increase in Guillain-Barre syndrome. Researchers also observed a higher-than-expected number of cases of encephalomyelitis, an inflammation of the brain and spinal cord, among those who received Moderna's first vaccine dose.
